Texas Health and Human Services [ [link removed] ]

Blue Gradient


Change in Preferred Drug List Status for the Smoking Cessation Drug Class Effective May 16, 2023

HHSC is aware of a drug shortage for the brand name Chantix [ [link removed] ] in the Smoking Cessation drug class due to a manufacturing delay of this product by Pfizer. In response to the preferred brand name Chantix shortage, HHSC removed the non-preferred status from the generic product, varenicline, on the preferred drug list.

*Other news:*


* Memorial Day Holiday to Delay Pharmacy Payments [ [link removed] ]
* HHSC to Implement Antimigraine Agents-Ergot Derivatives Clinical Prior Authorization on June 6 [ [link removed] ]
* HHSC to Implement Gattex Clinical Prior Authorization on June 6 [ [link removed] ]
* Members Sought for the Drug Utilization Review Board [ [link removed] ] (applications due June 9)
* Pharmacy Email Addresses Must Be Current in PEMS [ [link removed] ]








________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]